Hyperliquid Strategies Inc (PURR)

$3.70 +0.02 (0.54%)
Market Cap 26.05M
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,411,100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 7.08M
Stochastic %K N/A
Beta 1.48
Analysts Strong Buy
Price Target N/A

Company Profile

Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.

Industry: Capital Markets
Sector: Financial Services
Address:
477 Madison Avenue, New York, United States
Latest News on PURR
Hyperliquid Strategies Inc Announces $30 million Stock Repurchase Program

Dec 8, 2025, 9:20 AM EST - 13 hours ago

Hyperliquid Strategies Inc Announces $30 million Stock Repurchase Program

Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'

Dec 3, 2025, 5:45 PM EST - 5 days ago

Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

Dec 2, 2025, 4:30 PM EST - 6 days ago

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

SONN